Roche Ag

(OTC) RHHVF

Current Price$405.00

Market Cap$322.23B

Since IPO (2003)+568%

5 Year+23%

1 Year+30%

1 Month+0%

Roche Ag last closing stock price
Metric	Price	Date
Last close	USD 405.00	2026-07-17

Roche Ag stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-3.46%	USD 419.52	2026-07-10
1 month	+0.37%	USD 403.50	2026-06-17
3 month	+0%	USD 405.00	2026-04-17
Year to date	+1%	USD 401.00	2025-12-31
1 year	+30.18%	USD 311.10	2025-07-17
3 year	+41.29%	USD 286.65	2023-07-18
5 year	+23.14%	USD 328.90	2021-07-16
Since inception	+568%	USD 60.63	2003-06-25

Roche Ag Financials at a Glance

Market Cap

$322.23B

Revenue (TTM)

CHF 124.83B

Net Income (TTM)

CHF 21.16B

EPS (TTM)

$19.22

P/E Ratio

20.89

Dividend

$12.41

Beta (Volatility)

0.25 (Low)

Dividend

$12.41

Beta (Volatility)

0.25 (Low)

Price

$405.00

Volume

1,374

Open

$410.00

Price

$405.00

Volume

1,374

Open

$410.00

Previous Close

$405.00

Daily Range

$404.90 - $424.84

52-Week Range

$300.15 - $490.33

Estimated Earnings Date

Jul 23, 2026

Dividend

$12.41

Beta (Volatility)

0.25 (Low)

Price

$405.00

Volume

1,374

Open

$410.00

Previous Close

$405.00

Daily Range

$404.90 - $424.84

52-Week Range

$300.15 - $490.33

Estimated Earnings Date

Jul 23, 2026

RHHVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Roche Ag

Roche Holding AG operates as a global healthcare leader, specializing in both pharmaceuticals and diagnostics. The company is headquartered in Basel, Switzerland, and has a significant presence in key markets such as Germany and the United States.

Products and Services

Pharmaceuticals for oncology, neuroscience, and infectious diseases
In vitro diagnostic tests for various diseases, including cancer and diabetes
Diagnostic instruments and chemical reagents for medical testing

Growth Outlook

Recent partnership with Synlogic aims to innovate treatments for inflammatory bowel disease
Strong pipeline of new drugs expected to drive future revenue growth
Expansion in emerging markets enhances global reach and market share

Financial Highlights

Q4 2025 revenue of 30.59 billion CHF, reflecting strong market demand
Net income for Q2 2025 reached 7.41 billion CHF, showcasing profitability
TTM dividend yield of 2.95%, indicating consistent shareholder returns

Roche Holding AG is recognized for its commitment to innovation and quality in healthcare. The company's diverse product offerings and strong financial performance position it well for future growth. With a robust pipeline and strategic partnerships, Roche is poised to capitalize on emerging opportunities in the healthcare sector. The recent financial results demonstrate resilience and profitability, making it an attractive option for potential investors interested in the healthcare industry.

AI Generated • Jun 25, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

112,774

CEO

Thomas Schinecker, PhD

Website

www.roche.com

Headquarters

Basel, 4058, CH

RHHVF Financials

Key Financial Metrics (TTM)

Gross Margin

73.53%

Operating Margin

31.32%

Net Income Margin

20.94%

Return on Equity

41.23%

Return on Capital

23.97%

Return on Assets

12.79%

Earnings Yield

4.79%

Dividend Yield

3.06%

Payout Ratio

35.09%

Stock Overview

Market Cap

$322.23B

Shares Outstanding

795.62M

Volume

1.37K

Avg. Volume

4.26K

Financials (TTM)

Gross Profit

CHF 92.16B

Operating Income

CHF 32.25B

EBITDA

CHF 38.96B

Operating Cash Flow

CHF 38.43B

Capital Expenditure

-CHF 8.76B

Free Cash Flow

CHF 29.67B

Cash & ST Invst.

CHF 15.48B

Total Debt

CHF 33.19B

Roche Ag Performance Analysis

Roche Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	CHF 66,258,309,430	-3.5%
2023	2023-12-31	CHF 65,337,879,703	-1.4%
2024	2024-12-31	CHF 68,692,208,306	5.1%
2025	2025-12-31	CHF 74,072,268,768	7.8%

Roche Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-06-30	3.1%
Q4	2024-12-31	2.9%
Q2	2025-06-30	0.7%
Q4	2025-12-31	-4.0%

Roche Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	CHF 16.26	-8.2%
2023	2023-12-31	CHF 15.91	-2.1%
2024	2024-12-31	CHF 11.72	-26.4%
2025	2025-12-31	CHF 19.31	64.8%

Roche Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-06-30	43.9%
Q4	2024-12-31	-67.7%
Q2	2025-06-30	266.3%
Q4	2025-12-31	-26.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

CHF 30.59B

+2.6%

Gross Profit

CHF 21.94B

+6.2%

Gross Margin

71.74%

N/A

Market Cap

$322.23B

N/A

Market Cap/Employee

$3.12M

N/A

Employees

103,249

N/A

Net Income

CHF 5.47B

+25.5%

EBITDA

CHF 9.62B

+10.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

CHF 15.48B

+47.3%

Total Debt

CHF 33.19B

+7.8%

Accounts Receivable

CHF 11.90B

-8.2%

Inventory

CHF 7.48B

-3.4%

Long Term Debt

CHF 28.67B

+9.9%

Short Term Debt

CHF 4.52B

-3.7%

Return on Assets

12.79%

N/A

Return on Invested Capital

26.50%

N/A

Free Cash Flow

CHF 9.17B

+75.2%

Operating Cash Flow

CHF 11.24B

+42.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RHHBYRoche Holding AG

RHHBYRoche Holding AG$51.60+0.29%

RHHBFRoche Holding AG

RHHBFRoche Holding AG$435.00+2.59%

NVSNovartis AG

NVSNovartis AG$153.76+0.67%

NVSEFNovartis AG

NVSEFNovartis AG$151.90+0.00%

AZNAstraZeneca PLC

AZNAstraZeneca PLC$168.90-0.23%

BMYBristol-Myers Squibb Company

BMYBristol-Myers Squibb Company$60.74+0.38%

SNYSanofi

SNYSanofi$44.66+1.02%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$6.53-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98-0.04%

NFLXNetflix

NFLXNetflix$68.95-0.07%

NOKNokia

NOKNokia$10.12-0.03%

PATHUiPath

PATHUiPath$12.15+0.01%

JOBYJoby Aviation

JOBYJoby Aviation$7.23-0.01%

SOFISoFi Technologies

SOFISoFi Technologies$17.28-0.00%

Questions About RHHVF

What is the current price of Roche Ag?

Roche Ag is trading at $405.00 per share.

What is the 52-week range for Roche Ag?

Over the past 52 weeks, Roche Ag has traded between $300.15 and $490.33.

How much debt does Roche Ag have?

As of the most recent reporting period, Roche Ag reported total debt of CHF 41.89B.

How much cash does Roche Ag have on hand?

Roche Ag reported CHF 7.05B in cash and cash equivalents in its most recent financial results.

What is Roche Ag’s dividend yield?

Roche Ag currently has a dividend yield of 3.06%.

Roche Ag

Roche Ag Financials at a Glance

RHHVF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Roche Ag

RHHVF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Roche Ag Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RHHVF

What is the current price of Roche Ag?

What is the 52-week range for Roche Ag?

How much debt does Roche Ag have?

How much cash does Roche Ag have on hand?

What is Roche Ag’s dividend yield?

Premium Investing Services